The US Centers for Disease Control CDC and Prevention has granted clinical trial approval for an experimental Zika vaccine.
Earlier today, the companies announced a phase I study with 40 healthy subjects to evaluate the safety, tolerability, and efficacy of the drug.
As of May 2016, 58 countries and territories reported continuing mosquito-borne transmission of the Zika virus; the incidences of viral infection and medical conditions caused by the virus are expanding, not contracting.
The company plans to start clinical trials in a few weeks and expects to report the results later this year.
It certainly appears that things are moving quickly — and they most certainly are as far as these things g o— but it could still take years before GLS-5700 can be used in the field.
It s pretty remarkable that clinical testing for a disease that only attained emergency status a few months ago has already been slated for clinical testing.